BABA
Alibaba Group Holding Limited
BABA's outlook is improving, though it still trails on the overall score.
SHAK
Shake Shack Inc.
SHAK has the edge over BABA overall, supported by stronger valuation and stronger fundamentals.
BABA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Weak | |
| Healthy |
BABA's balance sheet is currently healthy, and its revenue is stable, but its profitability and cash flow are under pressure.
SHAK Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
SHAK's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
BABA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 16x | $69.66 | -26% |
| Fair | 20x | $86.59 | -8.2% |
| Current | 21x | $94.36 | — |
| Expensive | 26x | $115 | +22% |
Historical ranges are pointers, not guarantees.
BABA's PE is 21x, but its earnings don't support one, so it isn't a reliable read right now.
SHAK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 71x | $72.68 | — |
| Cheap | 75x | $77.60 | +6.8% |
| Fair | 153x | $158 | +117% |
| Expensive | 505x | $520 | +616% |
Historical ranges are pointers, not guarantees.
SHAK has the edge over BABA in the historical PE scenario, which offers more potential upside but is not a forecast.
BABA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for BABA, with profitability improving. However, they disagree widely on these estimates.
SHAK Forward outlook
There aren't enough analyst estimates for SHAK to show an outlook.
BABA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $4.42 | -52% |
| Q1 2026 | $6.57 | -18% |
| Q4 2025 | $5.79 | -22% |
| Q3 2025 | $7.85 | +49% |
| Q2 2025 | $9.27 | +116% |
| Q1 2025 | $8.06 | +71% |
| Q4 2024 | $7.47 | +24% |
| Q3 2024 | $5.26 | -35% |
BABA's earnings per share have fallen from their peak: $4.42 over the past year, against $9.27 in mid-2025. Its recent earnings include one-off gains.
SHAK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $1.03 | 0% |
| Q2 2026 | $0.94 | +100% |
| Q1 2026 | $0.98 | +238% |
| Q4 2025 | $1.09 | +354% |
| Q3 2025 | $1.03 | +442% |
| Q2 2025 | $0.47 | -27% |
| Q1 2025 | $0.29 | -49% |
| Q4 2024 | $0.24 | -50% |
SHAK has the edge over BABA on earnings, with stronger typical year-over-year growth.
BABA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $40.2B | +8.3% |
| Q1 2026 | $36.5B | +2.9% |
| Q4 2025 | $42.7B | +1.7% |
| Q3 2025 | $37.2B | +4.8% |
| Q2 2025 | $37.2B | +1.8% |
| Q1 2025 | $35.5B | +6.6% |
| Q4 2024 | $42B | +7.6% |
| Q3 2024 | $35.5B | +5.2% |
BABA's revenue has grown year over year for 16 quarters in a row: $40.2B last quarter, up 8.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.2% | -6.9 points |
| Q1 2026 | -0.3% | -12 points |
| Q4 2025 | 7.1% | -7.6 points |
| Q3 2025 | 2.2% | -13 points |
| Q2 2025 | 14% | -0.7 points |
| Q1 2025 | 12% | +5.4 points |
| Q4 2024 | 15% | +6.1 points |
| Q3 2024 | 15% | 0 points |
BABA has the edge over SHAK on profitability, with a higher operating margin.
SHAK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $423.3M | +15% |
| Q2 2026 | $417.6M | +17% |
| Q1 2026 | $366.7M | +14% |
| Q4 2025 | $400.5M | +22% |
| Q3 2025 | $367.4M | +16% |
| Q2 2025 | $356.5M | +13% |
| Q1 2025 | $320.9M | +10% |
| Q4 2024 | $328.7M | +15% |
SHAK has the edge over BABA on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.1% | 0 points |
| Q2 2026 | 5% | -1.3 points |
| Q1 2026 | -0.7% | -1.6 points |
| Q4 2025 | 4.7% | +1.6 points |
| Q3 2025 | 5% | +11 points |
| Q2 2025 | 6.3% | +2.9 points |
| Q1 2025 | 0.9% | +0.9 points |
| Q4 2024 | 3.1% | +3.6 points |
SHAK's operating margin was 5.1% last quarter, about level with the same quarter a year ago, near the top of its range since 2019.
BABA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$6.7B | -$4.1B |
| Q1 2026 | -$2.7B | +$1.5B |
| Q4 2025 | $1B | -90% |
| Q3 2025 | -$3.2B | -254% |
| Q2 2025 | -$2.7B | -182% |
| Q1 2025 | -$4.2B | -12231% |
| Q4 2024 | $10.4B | -4.8% |
| Q3 2024 | $2.1B | -62% |
BABA's free cash flow has turned negative after years in the green: −$11.6B over the past year.
SHAK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13.1M | -45% |
| Q2 2026 | -$736K | -103% |
| Q1 2026 | -$38.7M | -2170% |
| Q4 2025 | $4M | -62% |
| Q3 2025 | $23.7M | +237% |
| Q2 2025 | $26.9M | +31% |
| Q1 2025 | $1.9M | +$4.3M |
| Q4 2024 | $10.4M | +23% |
SHAK has the edge over BABA on cash flow, with more consistent year-over-year improvement.
BABA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +11.1M shares |
| 1 year | +0.9% | +21.4M shares |
| 3 years | -6.2% | -161M shares |
| 5 years | -12% | -339M shares |
| Available history | -8.4% | -221M shares |
BABA has 2.4B diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $269.8M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
BABA spent $270M buying back its own shares over the past year, after none the year before.
SHAK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +44K shares |
| 1 year | +0.1% | +36K shares |
| 3 years | -4.7% | -2.1M shares |
| 5 years | +7.1% | +2.8M shares |
| Available history | +30% | +9.7M shares |
SHAK has the edge over BABA on shareholder dilution, with a more favorable share count trend.
BABA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.8x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | 0.1x | Very low |
| Q3 2024 | -0.2x | Net Cash |
BABA's net debt is less than a year of its operating earnings (EBITDA).
SHAK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.4x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.4x | Net Cash |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -0.7x | Net Cash |
| Q2 2025 | -0.7x | Net Cash |
| Q1 2025 | -0.6x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
SHAK has the edge over BABA on leverage, with a lower net debt burden relative to earnings.
BABA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 12.7 | Oversold |
BABA's weekly RSI is 38 (neutral) and its Stochastic is 13 (oversold).
SHAK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.1 | Neutral |
| Stochastic | 75.5 | Neutral |
SHAK's weekly RSI is 53 (neutral) and its Stochastic is 76 (neutral).
BABA PE vs Consumer Cyclical Sector
| Metric | BABA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 18x | 19% above |
| PE % | 60 | 47 | 13 pts above |
BABA has the edge over SHAK on valuation relative to its sector.
SHAK PE vs Consumer Cyclical Sector
| Metric | SHAK | Sector median | Relative |
|---|---|---|---|
| PE | 71x | 18x | 292% above |
| PE % | 11 | 47 | 36 pts below |
SHAK is trading at 71x earnings, a 292% premium to the Consumer Cyclical sector's median of 18x.
BABA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $104.7 | 9.9% below |
| 20 week MA | $111.1 | 15% below |
| 50 week MA | $128.0 | 26% below |
| 100 week MA | $127.7 | 26% below |
| 200 week MA | $106.4 | 11% below |
BABA is in a downtrend: it's below all five of its weekly moving averages, and 11% below its 200-week average.
SHAK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $66.7 | 9% above |
| 20 week MA | $65.3 | 11% above |
| 50 week MA | $75.9 | 4.3% below |
| 100 week MA | $92.0 | 21% below |
| 200 week MA | $86.9 | 16% below |
SHAK has the edge over BABA on trend strength, trading above more of its moving averages.
BABA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $215.5 | $222.0 | +3% |
| 2021 | $222.0 | $118.7 | -47% |
| 2022 | $118.7 | $85.7 | -28% |
| 2023 | $85.7 | $77.5 | -9.5% |
| 2024 | $77.5 | $85.1 | +9.7% |
| 2025 | $85.1 | $152.2 | +79% |
| 2026 YTD | $152.2 | $94.4 | -38% |
BABA has finished lower in three of the last six years. It's down 38% so far in 2026.
SHAK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.5 | $87.8 | +45% |
| 2021 | $87.8 | $74.5 | -15% |
| 2022 | $74.5 | $44.9 | -40% |
| 2023 | $44.9 | $74.1 | +65% |
| 2024 | $74.1 | $132.6 | +79% |
| 2025 | $132.6 | $83.8 | -37% |
| 2026 YTD | $83.8 | $72.7 | -13% |
SHAK has the edge over BABA on returns for 2026, with the stronger performance.